mTOR as a key regulator in maintaining skeletal muscle mass

Frontiers in Physiology

Volumn 8, Issue OCT, 2017, Pages

  Yoon, Mee Sup ^a  

^a Gachon University   (South Korea)

Author keywords

Atrophy; Hypertrophy; mTOR; Sarcopenia; Skeletal muscle

Indexed keywords

GLUCOCORTICOID; MAMMALIAN TARGET OF RAPAMYCIN; MYOSTATIN; PHOSPHATIDIC ACID; SOMATOMEDIN C;

ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; MECHANICAL STIMULATION; MTOR SIGNALING; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PHENOTYPE; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SARCOPENIA; SKELETAL MUSCLE;

EID: 85031807112     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00788     Document Type: Review

References (91)

1. Aguilar, V., Alliouachene, S., Sotiropoulos, A., Sobering, A., Athea, Y., Djouadi, F., et al. (2007). S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab. 5, 476-487. doi: 10.1016/j.cmet.2007.05.006
2. Allen, D. L., Cleary, A. S., Hanson, A. M., Lindsay, S. F., and Reed, J. M. (2010). CCAAT/enhancer binding protein-d expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am. J. Physiol. Regul. Integr. Compar. Physiol. 299, R1592-R1601. doi: 10.1152/ajpregu.00247.2010
3. Amirouche, A., Durieux, A. C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., et al. (2009). Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 150, 286-294. doi: 10.1210/en.2008-0959
4. Barton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N., and Sweeney, H. L. (1998). Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. U.S.A. 95, 15603-15607. doi: 10.1073/pnas.95.26.15603
5. Bentzinger, C. F., Romanino, K., Cloetta, D., Lin, S., Mascarenhas, J. B., Oliveri, F., et al. (2008). Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8, 411-424. doi: 10.1016/j.cmet.2008.10.002
6. Bjedov, I., Toivonen, J. M., Kerr, F., Slack, C., Jacobson, J., Foley, A., et al. (2010). Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 11, 35-46. doi: 10.1016/j.cmet.2009.11.010
7. Braun, T. P., and Marks, D. L. (2015). The regulation of muscle mass by endogenous glucocorticoids. Front. Physiol. 6:12. doi: 10.3389/fphys.2015.00012
8. Castets, P., Lin, S., Rion, N., Di Fulvio, S., Romanino, K., Guridi, M., et al. (2013). Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. 17, 731-744. doi: 10.1016/j.cmet.2013.03.015
9. Chale-Rush, A., Morris, E. P., Kendall, T. L., Brooks, N. E., and Fielding, R. A. (2009). Effects of chronic overload on muscle hypertrophy and mTOR signaling in young adult and aged rats. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1232-1239. doi: 10.1093/gerona/glp146
10. Coleman, M. E., DeMayo, F., Yin, K. C., Lee, H. M., Geske, R., Montgomery, C., et al. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109-12116. doi: 10.1074/jbc.270.20.12109
11. Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., et al. (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 19, 422-424. doi: 10.1096/fj.04-2640fje
12. Deane, C. S., Hughes, D. C., Sculthorpe, N., Lewis, M. P., Stewart, C. E., and Sharples, A. P. (2013). Impaired hypertrophy in myoblasts is improved with testosterone administration. J. Steroid Biochem. Mol. Biol. 138, 152-161. doi: 10.1016/j.jsbmb.2013.05.005
13. DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., and Ellisen, L. W. (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 22, 239-251. doi: 10.1101/gad.1617608
14. Dibble, C. C., and Manning, B. D. (2013). Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat. Cell Biol. 15, 555-564. doi: 10.1038/ncb2763
15. Drummond, M. J., Dreyer, H. C., Pennings, B., Fry, C. S., Dhanani, S., Dillon, E. L., et al. (2008). Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J. Appl. Physiol. 104, 1452-1461. doi: 10.1152/japplphysiol.00021.2008
16. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., and Chen, J. (2001). Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942-1945. doi: 10.1126/science.1066015
17. Florini, J. R., Ewton, D. Z., and Roof, S. L. (1991). Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5, 718-724. doi: 10.1210/mend-5-5-718
18. Fry, C. S., Drummond, M. J., Glynn, E. L., Dickinson, J. M., Gundermann, D. M., Timmerman, K. L., et al. (2011). Aging impairs contraction-induced human skeletal muscle mTORC1 signaling and protein synthesis. Skelet. Muscle 1:11. doi: 10.1186/2044-5040-1-11
19. Ge, Y., Sun, Y., and Chen, J. (2011). IGF-II is regulated by microRNA-125b in skeletal myogenesis. J. Cell Biol. 192, 69-81. doi: 10.1083/jcb.201007165
20. Glass, D. J. (2003). Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9, 344-350. doi: 10.1016/S1471-4914(03)00138-2
21. Glass, D. J. (2005). Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37, 1974-1984. doi: 10.1016/j.biocel.2005.04.018
22. Gong, Z., Kennedy, O., Sun, H., Wu, Y., Williams, G. A., Klein, L., et al. (2014). Reductions in serum IGF-1 during aging impair health span. Aging Cell 13, 408-418. doi: 10.1111/acel.12188
23. Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., et al. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859-871. doi: 10.1016/j.devcel.2006.10.007
24. Hornberger, T. A. (2011). Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int. J. Biochem. Cell Biol. 43, 1267-1276. doi: 10.1016/j.biocel.2011.05.007
25. Hornberger, T. A., Chu, W. K., Mak, Y. W., Hsiung, J. W., Huang, S. A., and Chien, S. (2006). The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 103, 4741-4746. doi: 10.1073/pnas.0600678103
26. Hornberger, T. A., Stuppard, R., Conley, K. E., Fedele, M. J., Fiorotto, M. L., Chin, E. R., et al. (2004). Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem. J. 380, 795-804. doi: 10.1042/bj20040274
27. Huang, J., and Manning, B. D. (2008). The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J. 412, 179-190. doi: 10.1042/BJ20080281
28. Izumiya, Y., Hopkins, T., Morris, C., Sato, K., Zeng, L., Viereck, J., et al. (2008). Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 7, 159-172. doi: 10.1016/j.cmet.2007.11.003
29. Jacobs, B. L., You, J. S., Frey, J. W., Goodman, C. A., Gundermann, D. M., and Hornberger, T. A. (2013). Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome. J. Physiol. 591, 4611-4620. doi: 10.1113/jphysiol.2013.256339
30. Johnson, S. C., Martin, G. M., Rabinovitch, P. S., and Kaeberlein, M. (2013a). Preserving youth: does rapamycin deliver? Sci. Transl. Med. 5:211fs40. doi: 10.1126/scitranslmed.3007316
31. Johnson, S. C., Rabinovitch, P. S., and Kaeberlein, M. (2013b). mTOR is a key modulator of ageing and age-related disease. Nature 493, 338-345. doi: 10.1038/nature11861
32. Korolchuk, V. I., Saiki, S., Lichtenberg, M., Siddiqi, F. H., Roberts, E. A., Imarisio, S., et al. (2011). Lysosomal positioning coordinates cellular nutrient responses. Nat. Cell Biol. 13, 453-460. doi: 10.1038/ncb2204
33. Laplante, M., and Sabatini, D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274-293. doi: 10.1016/j.cell.2012.03.017
34. Lee, S. J. (2007). Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS ONE 2:e789. doi: 10.1371/journal.pone.0000789
35. Leger, B., Derave, W., De Bock, K., Hespel, P., and Russell, A. P. (2008). Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenat. Res. 11, 163B-175B. doi: 10.1089/rej.2007.0588
36. Li, M., Verdijk, L. B., Sakamoto, K., Ely, B., van Loon, L. J., and Musi, N. (2012). Reduced AMPK-ACC and mTOR signaling in muscle from older men, and effect of resistance exercise. Mech. Ageing Dev. 133, 655-664. doi: 10.1016/j.mad.2012.09.001
37. Lipina, C., Kendall, H., McPherron, A. C., Taylor, P. M., and Hundal, H. S. (2010). Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Lett. 584, 2403-2408. doi: 10.1016/j.febslet.2010.04.039
38. Lokireddy, S., Mouly, V., Butler-Browne, G., Gluckman, P. D., Sharma, M., Kambadur, R., et al. (2011). Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am. J. Physiol. Cell Physiol. 301, C1316-C1324. doi: 10.1152/ajpcell.00114.2011
39. Ma, K., Mallidis, C., Artaza, J., Taylor, W., Gonzalez-Cadavid, N., and Bhasin, S. (2001). Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am. J. Physiol. Endocrinol. Metab. 281, E1128-E1136.
40. Ma, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., Gonzalez-Cadavid, N., et al. (2003). Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am. J. Physiol. Endocrinol. Metab. 285, E363-E371. doi: 10.1152/ajpendo.00487.2002
41. Ma, X. M., and Blenis, J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318. doi: 10.1038/nrm2672
42. Manning, B. D., and Cantley, L. C. (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274. doi: 10.1016/j.cell.2007.06.009
43. Markofski, M. M., Dickinson, J. M., Drummond, M. J., Fry, C. S., Fujita, S., Gundermann, D. M., et al. (2015). Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women. Exp. Gerontol. 65, 1-7. doi: 10.1016/j.exger.2015.02.015
44. Matsumoto, A., Pasut, A., Matsumoto, M., Yamashita, R., Fung, J., Monteleone, E., et al. (2017). mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature 541, 228-232. doi: 10.1038/nature21034
45. McCarthy, J. J., and Esser, K. A. (2010). Anabolic and catabolic pathways regulating skeletal muscle mass. Curr. Opin. Clin. Nutr. Metab. Care 13, 230-235. doi: 10.1097/MCO.0b013e32833781b5
46. McFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., et al. (2006). Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J. Cell. Physiol. 209, 501-514. doi: 10.1002/jcp.20757
47. McPherron, A. C., Lawler, A. M., and Lee, S. J. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90. doi: 10.1038/387083a0
48. Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., and Yamamoto, K. R. (2009). DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410. doi: 10.1126/science.1164265
49. Menconi, M., Fareed, M., O'Neal, P., Poylin, V., Wei, W., and Hasselgren, P. O. (2007). Role of glucocorticoids in the molecular regulation of muscle wasting. Crit. Care Med. 35, S602-S608. doi: 10.1097/01.CCM.0000279194.11328.77
50. Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A. J., Takahashi, H., et al. (2014). Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771-785. doi: 10.1016/j.cell.2013.11.049
51. Munck, A., Guyre, P. M., and Holbrook, N. J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5, 25-44. doi: 10.1210/edrv-5-1-25
52. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., et al. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200. doi: 10.1038/84839
53. O'Neil, T. K., Duffy, L. R., Frey, J. W., and Hornberger, T. A. (2009). The role of phosphoinositide 3-kinase and phosphatidic acid in the regulation of mammalian target of rapamycin following eccentric contractions. J. Physiol. 587, 3691-3701. doi: 10.1113/jphysiol.2009.173609
54. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M., and Schiaffino, S. (2002). A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. U.S.A. 99, 9213-9218. doi: 10.1073/pnas.142166599
55. Parkington, J. D., LeBrasseur, N. K., Siebert, A. P., and Fielding, R. A. (1985). Contraction-mediated mTOR, p70S6k, and ERK1/2 phosphorylation in aged skeletal muscle. J. Appl. Physiol. 97, 243-248.
56. Passtoors, W. M., Beekman, M., Deelen, J., van der Breggen Maier, A. B., Guigas, B., et al. (2013). Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell 12, 24-31. doi: 10.1111/acel.12015
57. Pelosi, L., Giacinti, C., Nardis, C., Borsellino, G., Rizzuto, E., Nicoletti, C., et al. (2007). Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J. 21, 1393-1402. doi: 10.1096/fj.06-7690com
58. Powers, R. W. III., Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., and Fields, S. (2006). Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 20, 174-184. doi: 10.1101/gad.1381406
59. Rabinovsky, E. D., Gelir, E., Gelir, S., Lui, H., Kattash, M., DeMayo, F. J., et al. (2003). Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J. 17 53-55. doi: 10.1096/fj.02-0183fje
60. Ramos, F. J., Chen, S. C., Garelick, M. G., Dai, D. F., Liao, C. Y., Schreiber, K. H., et al. (2012). Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci. Transl. Med. 4:144ra103. doi: 10.1126/scitranslmed.3003802
61. Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C., et al. (2009). Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187, 859-874. doi: 10.1083/jcb.200903131
62. Robida-Stubbs, S., Glover-Cutter, K., Lamming, D. W., Mizunuma, M., Narasimhan, S. D., Neumann-Haefelin, E., et al. (2012). TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15, 713-724. doi: 10.1016/j.cmet.2012.04.007
63. Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., et al. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741. doi: 10.1126/science.286.5445.1738
64. Sakuma, K., Aoi, W., and Yamaguchi, A. (2014). The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy. Front. Aging Neurosci. 6:230. doi: 10.3389/fnagi.2014.00230
65. Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., and Sabatini, D. M. (2010). Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303. doi: 10.1016/j.cell.2010.02.024
66. Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501. doi: 10.1126/science.1157535
67. Sandri, M., Barberi, L., Bijlsma, A. Y., Blaauw, B., Dyar, K. A., Milan, G., et al. (2013). Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 14, 303-323. doi: 10.1007/s10522-013-9432-9
68. Sarbassov, D. D., Ali, S. M., and Sabatini, D. M. (2005). Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603. doi: 10.1016/j.ceb.2005.09.009
69. Sartori, R., Gregorevic, P., and Sandri, M. (2014). TGFbeta and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol. Metab. 25, 464-471. doi: 10.1016/j.tem.2014.06.002
70. Sartori, R., Milan, G., Patron, M., Mammucari, C., Blaauw, B., Abraham, R., et al. (2009). Smad2 and 3 transcription factors control muscle mass in adulthood. Am. J. Physiol. Cell Physiol. 296, C1248-C1257. doi: 10.1152/ajpcell.00104.2009
71. Saxton, R. A., and Sabatini, D. M. (2017). mTOR signaling in growth, metabolism, and disease. Cell 169, 361-371. doi: 10.1016/j.cell.2017.02.004
72. Schakman, O., Gilson, H., and Thissen, J. P. (2008). Mechanisms of glucocorticoid-induced myopathy. J. Endocrinol. 197, 1-10. doi: 10.1677/JOE-07-0606
73. Schiaffino, S., and Mammucari, C. (2011). Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet. Muscle 1:4. doi: 10.1186/2044-5040-1-4
74. Sharples, A. P., Al-Shanti, N., Hughes, D. C., Lewis, M. P., and Stewart, C. E. (2013). The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy. Growth Horm. IGF Res. 23, 53-61. doi: 10.1016/j.ghir.2013.03.004
75. Shimizu, N., Yoshikawa, N., Ito, N., Maruyama, T., Suzuki, Y., Takeda, S., et al. (2011). Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 13, 170-182. doi: 10.1016/j.cmet.2011.01.001
76. Song, Z., Moore, D. R., Hodson, N., Ward, C., Dent, J. R., O'Leary, M. F., et al. (2017). Resistance exercise initiates mechanistic target of rapamycin (mTOR) translocation and protein complex co-localisation in human skeletal muscle. Sci. Rep. 7:5028. doi: 10.1038/s41598-017-05483-x
77. Spangenburg, E. E., Le Roith, D., Ward, C. W., and Bodine, S. C. (2008). A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J. Physiol. 586, 283-291. doi: 10.1113/jphysiol.2007.141507
78. Sun, Y., Ge, Y., Drnevich, J., Zhao, Y., Band, M., and Chen, J. (2010). Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol. 189, 1157-1169. doi: 10.1083/jcb.200912093
79. Timmerman, K. L., Lee, J. L., Fujita, S., Dhanani, S., Dreyer, H. C., Fry, C. S., et al. (2010). Pharmacological vasodilation improves insulin-stimulated muscle protein anabolism but not glucose utilization in older adults. Diabetes 59, 2764-2771. doi: 10.2337/db10-0415
80. Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., and Glass, D. J. (2009). Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am. J. Physiol. Cell Physiol. 296, C1258-C1270. doi: 10.1152/ajpcell.00105.2009
81. Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., et al. (2004). Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205. doi: 10.1038/nature02866
82. Vandenburgh, H. H., Karlisch, P., Shansky, J., and Feldstein, R. (1991). Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. 260, C475-C484.
83. Walston, J. D. (2012). Sarcopenia in older adults. Curr. Opin. Rheumatol. 24, 623-627. doi: 10.1097/BOR.0b013e328358d59b
84. Wang, X., Devaiah, S. P., Zhang, W., and Welti, R. (2006). Signaling functions of phosphatidic acid. Prog. Lipid Res. 45, 250-278. doi: 10.1016/j.plipres.2006.01.005
85. Welle, S., Burgess, K., and Mehta, S. (2009). Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. Am. J. Physiol. Endocrinol. Metab. 296, E567-E572. doi: 10.1152/ajpendo.90862.2008
86. Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., et al. (2012). Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J. Cell Biol. 197, 997-1008. doi: 10.1083/jcb.201109091
87. Xie, Y., Zhang, P., Espinoza, D., Perry, B., Rahnert, J., Zheng, B., et al. (2017). Glucocorticoid-induced inhibition of AKT leads to CREB phosphorylation and increased myostatin expression via a PDE/cAMP/PKA pathway in skeletal muscle. FASEB J. 31:929.922.
88. Yoon, M. S., Du, G., Backer, J. M., Frohman, M. A., and Chen, J. (2011). Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway. J. Cell Biol. 195, 435-447. doi: 10.1083/jcb.201107033
89. Yoon, M. S., Rosenberger, C. L., Wu, C., Truong, N., Sweedler, J. V., and Chen, J. (2015). Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid. Mol. Cell 58, 549-556. doi: 10.1016/j.molcel.2015.03.028
90. You, J. S., Lincoln, H. C., Kim, C. R., Frey, J. W., Goodman, C. A., Zhong, X. P., et al. (2014). The role of diacylglycerol kinase zeta and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. J. Biol. Chem. 289, 1551-1563. doi: 10.1074/jbc.M113.531392
91. Zhang, Y., Yu, B., He, J., and Chen, D. (2016). From nutrient to MicroRNA: a novel insight into cell signaling involved in skeletal muscle development and disease. Int. J. Biol. Sci. 12, 1247-1261. doi: 10.7150/ijbs.16463